A method for simultaneous T1, T2 and Apparent Diffusion Coefficient (ADC) mapping, STimulated-Echo based Mapping (STEM), has been proposed to achieve rapid and co-registered multi-slice T1, T2 and ADC maps within a moderate scan time. In this study, the STEM method is optimized for prostate imaging and evaluated in 16 patients with suspected prostate cancer (PCa) or benign prostatic hyperplasia (BPH). T1, T2 and ADC maps were successfully estimated and compared among BPH, PCa and healthy prostate tissues.
Protocol Optimization: In order to determine STEM acquisition parameters, the choice of mixing-time (TM), echo-time (TE) and b-values was formulated as a minimax optimization problem of the Cramér-Rao Lower Bound (CRLB)-based standard deviation of the resulting T1, T2 and ADC estimates5. The range of T1, T2 and ADC values for the optimization were selected as 600 to 2000ms, 50 to 200ms and 800 to 1700 10-6mm2/s, respectively, to cover the values commonly observed in prostate imaging2-4,6. The optimization also included constraints on scanner configuration as well as the achievable TM, TE and b-values. The minimum b-value was set as 100s/mm2 (similar to our local clinical DWI protocol) to avoid potential IVIM effects.
Patient Evaluation: After IRB approval and informed written consent, 16 patients with suspected PCa and/or BPH were recruited to evaluate the T1, T2 and ADC values from STEM acquisitions. STEM acquisitions were performed with in-plane resolution = 2mm$$$\times$$$2mm, slice thickness = 4.8mm, acquisition bandwidth = $$$\pm$$$62.5kHz, TR=4s, diffusion direction = three orthogonal directions and parallel imaging factor = 2 with partial Fourier acquisition. The overall scan time is 3 minutes and 56 seconds for STEM.
T1 relaxation, T2 relaxation and ADC maps, are jointly estimated by voxel-wise non-linear least-squares fitting of the following equation: $$S=A(1-e^{\frac{-TR_{eff}}{T1}})e^{-\frac{TM}{T1}}e^{-\frac{TE}{T2}}e^{-bADC}$$, where $$TR_{eff}=TR-TM-\frac{TE}{2}$$.
ROIs were drawn in the healthy peripheral zone (PZ), healthy central gland (CG), PCa and BPH respectively for each patient. Two-sample t-test was applied without assuming equal variance to evaluate the difference of measurements between lesion and healthy tissue.
[1] Foltz WD, Wu A, Chung P, et al. (2013). Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer. J Magn Reson Imag 2013;37(4):909-916.
[2] Gibbs P, Tozer DJ, Liney GP, Turnbull LW. Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate. Magn Reson Med 2001;46(6):1054-1058.
[3] Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA. Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI. J Magn Reson Imag 2009; 30(2):327-334.
[4] Yu AC, Badve C, Ponsky LE, et al. Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer. Radiology 2017;283(3):729-738.
[5] Zhang, Y., Wells, S.A. and Hernando, D., 2018. Stimulated echo based mapping (STEM) of T1, T2, and apparent diffusion coefficient: validation and protocol optimization. Magnetic resonance in medicine.
[6] De Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology. 2004 Mar;230(3):652-9.